Q2 EPS Estimates for HealthEquity Raised by Zacks Research

HealthEquity, Inc. (NASDAQ:HQY) – Equities researchers at Zacks Research boosted their Q2 2027 earnings per share (EPS) estimates for shares of HealthEquity in a report released on Tuesday, September 23rd. Zacks Research analyst Team now anticipates that the company will post earnings of $1.00 per share for the quarter, up from their previous forecast of $0.94. The consensus estimate for HealthEquity’s current full-year earnings is $2.32 per share. Zacks Research also issued estimates for HealthEquity’s Q4 2027 earnings at $0.93 EPS.

Several other brokerages also recently issued reports on HQY. Raymond James Financial restated a “strong-buy” rating and set a $120.00 price objective (up from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a research note on Friday, June 6th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of HealthEquity from $98.00 to $115.00 and gave the stock a “buy” rating in a research note on Thursday, June 5th. Barrington Research reaffirmed an “outperform” rating and issued a $125.00 target price on shares of HealthEquity in a research note on Friday, August 29th. Finally, Jefferies Financial Group lifted their target price on shares of HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research note on Wednesday, September 3rd. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, HealthEquity currently has a consensus rating of “Buy” and an average target price of $119.77.

HealthEquity Trading Up 2.0%

Shares of HealthEquity stock opened at $96.16 on Thursday. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23. HealthEquity has a 1 year low of $74.07 and a 1 year high of $116.65. The company has a market capitalization of $8.29 billion, a P/E ratio of 58.28, a P/E/G ratio of 1.35 and a beta of 0.50. The business has a 50 day moving average price of $92.63 and a 200 day moving average price of $93.92.

Insider Buying and Selling at HealthEquity

In other news, EVP Michael Henry Fiore sold 1,794 shares of the business’s stock in a transaction on Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the completion of the sale, the executive vice president directly owned 53,225 shares of the company’s stock, valued at $5,414,579.25. The trade was a 3.26% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Delano Ladd sold 6,000 shares of the business’s stock in a transaction on Friday, September 19th. The shares were sold at an average price of $94.11, for a total transaction of $564,660.00. Following the sale, the executive vice president directly owned 79,456 shares of the company’s stock, valued at $7,477,604.16. This represents a 7.02% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is owned by insiders.

Institutional Trading of HealthEquity

Several institutional investors have recently made changes to their positions in HQY. Cetera Investment Advisers grew its stake in shares of HealthEquity by 6.7% during the 4th quarter. Cetera Investment Advisers now owns 3,572 shares of the company’s stock valued at $343,000 after buying an additional 225 shares during the period. GTS Securities LLC purchased a new stake in HealthEquity during the 4th quarter worth $239,000. Forum Financial Management LP purchased a new stake in HealthEquity during the 4th quarter worth $214,000. Wealth Enhancement Advisory Services LLC boosted its position in HealthEquity by 40.2% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 5,115 shares of the company’s stock worth $491,000 after purchasing an additional 1,466 shares during the period. Finally, Versant Capital Management Inc purchased a new stake in HealthEquity during the 1st quarter worth $28,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.